Active control of pharmacokinetics using light-responsive polymer-drug conjugates for boron neutron capture therapy.

Autor: Tokura D; Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan; Department of Life Science and Technology, School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan., Konarita K; Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan; Department of Life Science and Technology, School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan., Suzuki M; Division of Particle Radiation Oncology, Particle Radiation Oncology Research Center, Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2-1010 Asashiro-nishi, Kumatori-cho, Sennan-gun, Osaka 590-0494, Japan., Ogata K; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan; Department of Life Science and Technology, School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan., Honda Y; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan; Department of Life Science and Technology, School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan; Innovation Center of Nanomedicine (iCONM), Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan., Miura Y; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan; Department of Life Science and Technology, School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan., Nishiyama N; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan; Department of Life Science and Technology, School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan; Innovation Center of Nanomedicine (iCONM), Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan., Nomoto T; Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan; Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan. Electronic address: nomoto-t@g.ecc.u-tokyo.ac.jp.

Publikováno v: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Jul; Vol. 371, pp. 445-454. Date of Electronic Publication: 2024 Jun 08.

Fibrosis-4 index identifies worsening renal function associated with adverse outcomes in acute heart failure.

Autor: Tsuda K; Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Department of Cardiology, Hokusetsu General Hospital, Osaka, Japan., Maeda D; Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Kanzaki Y; Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Sakane K; Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Okuno T; Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Nakayama S; Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Tokura D; Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Hasegawa H; Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Hoshiga M; Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan.

Publikováno v: ESC heart failure [ESC Heart Fail] 2023 Jun; Vol. 10 (3), pp. 1726-1734. Date of Electronic Publication: 2023 Feb 25.

Prognostic value of the liver fibrosis marker fibrosis-5 index in patients with acute heart failure.

Autor: Maeda D; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Kanzaki Y; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Sakane K; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Tsuda K; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Akamatsu K; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Hourai R; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Okuno T; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Tokura D; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Nakayama S; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Hasegawa H; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Morita H; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Ito T; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Hoshiga M; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan.

Publikováno v: ESC heart failure [ESC Heart Fail] 2022 Apr; Vol. 9 (2), pp. 1380-1387. Date of Electronic Publication: 2022 Feb 03.

Effect of stitch tension of non-crimp fabric on the mechanical properties of CFRTP

Autor: Tanaka, K., Tokura, D., Katayama, T.

Publikováno v: In Recent Advances in Structural Integrity Analysis: Proceedings of the International Congress (APCF/SIF-2014) 2015:331-335

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.